Gunnar F. Kaufmann

Insider Reports History

Location
San Diego, CA
Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gunnar F. Kaufmann:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Scientific Officer Common Stock 94,726 $46,994 $0.4961 14 Jun 2023 Direct

Insider Reports Filed by Gunnar F. Kaufmann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123036994-kaufmann-gunnar-f-2023-06-12 Oncternal Therapeutics, Inc. 12 Jun 2023 2 +$9,824 4 Chief Scientific Officer 14 Jun 2023, 16:00
/report/000120919123012397-kaufmann-gunnar-f-2023-02-21 Oncternal Therapeutics, Inc. 21 Feb 2023 1 $0 4 Chief Scientific Officer 23 Feb 2023, 19:00
/report/000120919123002030-kaufmann-gunnar-f-2023-01-03 Oncternal Therapeutics, Inc. 03 Jan 2023 1 -$6,391 4 Chief Scientific Officer 05 Jan 2023, 17:00
/report/000120919122043738-kaufmann-gunnar-f-2022-07-28 Oncternal Therapeutics, Inc. 28 Jul 2022 2 $0 4 Chief Scientific Officer 01 Aug 2022, 18:21
/report/000120919122004582-kaufmann-gunnar-f-2022-01-20 Oncternal Therapeutics, Inc. 20 Jan 2022 1 $0 4 Chief Scientific Officer 24 Jan 2022, 15:00
/report/000120919122001972-kaufmann-gunnar-f-2022-01-03 Oncternal Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Scientific Officer 05 Jan 2022, 18:00